Health Sciences Acquisitions Corporation 2
HSAQ · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $3 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2 | $0 | $0 | $0 |
| % Margin | 92.3% | – | – | – |
| R&D Expenses | $43 | $0 | $0 | $0 |
| G&A Expenses | $0 | $3 | $0 | $0 |
| SG&A Expenses | $24 | $3 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $67 | $3 | $0 | $0 |
| Operating Income | -$64 | -$3 | -$0 | -$0 |
| % Margin | -2,437.5% | – | – | – |
| Other Income/Exp. Net | $3 | $0 | $0 | $0 |
| Pre-Tax Income | -$61 | -$3 | -$0 | -$0 |
| Tax Expense | $0 | -$0 | -$0 | $0 |
| Net Income | -$61 | -$2 | -$0 | -$0 |
| % Margin | -2,313.3% | – | – | – |
| EPS | -1.66 | -0.15 | -0.018 | -0.009 |
| % Growth | -1,006.7% | -738% | -108.1% | – |
| EPS Diluted | -1.66 | -0.15 | -0.018 | -0.009 |
| Weighted Avg Shares Out | 36,821 | 16 | 20 | 20 |
| Weighted Avg Shares Out Dil | 36,821 | 16 | 20 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | -$0 | -$0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$64 | -$3 | -$0 | -$0 |
| % Margin | -2,437.5% | – | – | – |